“Is this FDA approved?” is the question your patients ask most, and the one clinics get wrong most. Whether the question is about exosomes, PRP, or stem cell products, the honest answer is a compliance checkpoint and a trust opportunity at once. Patients ask “is exosome therapy FDA approved” and how you answer matters. This guide gives you the accurate answer and a script for every channel.
TLDR: The “Is this FDA approved?” question shows up on your website, in social comments, in DMs, in consults, in reviews, and in emails. The accurate answer is the same everywhere, but the delivery changes by channel. There are currently no FDA-approved exosome products. PRP and stem cell answers have specific nuances. Getting it wrong creates real legal risk. This guide covers the accurate answer, a channel-by-channel script, and an FDA terminology glossary.
Important Note This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. All marketing and patient communication strategies should be reviewed by qualified legal counsel before implementation. Regen Portal is a marketing company, not a law firm or compliance consultancy.
Every regen clinic gets the same question. A patient on the website, a commenter on social, someone in a DM, all asking the same thing. Is this FDA approved?
It is the most important compliance question in regen marketing. It is also the one clinics handle worst. Some answer wrong. Some stay vague. Some let the patient assume the answer.
This guide fixes that. You will get the accurate answer for each service, a script for every channel, and a glossary that clears up the FDA terms clinics confuse most.
Why This Is The Most Important Compliance Question
This one question carries more risk than almost any other. How you answer it can be the difference between honest marketing and a regulatory problem. That is why it deserves a clear plan.
The question goes to the heart of FDA rules. Implying a product is approved when it is not is a serious misstatement. The FTC treats it as a deceptive claim. The FDA treats it as a labeling problem.
Yet most clinics answer it on instinct, in the moment, with no agreed framework. The answer changes depending on who is at the front desk that day. That gap is a risk all by itself.
What this means for your practice: Treat “Is this FDA approved?” as a planned answer, not an improvised one. Every person who speaks for your clinic should give the same accurate response.
The Accurate Answer, In Plain Terms
The honest answer depends on the service, and each has a nuance. Here is the accurate version for the three most common.
For exosomes, the answer is direct. There are currently no FDA-approved exosome products for human use. State that plainly. The FDA’s tissue products page is the source, and our post on what you can say about exosomes covers the language.
For PRP, the nuance trips clinics up. The device used to prepare PRP may be FDA-cleared for a specific purpose, such as bone graft handling. That does not make the PRP procedure itself “FDA approved” in the way a patient hears it. The two are different things. Our complete PRP compliance rules cover the detail.
For stem cell products, the distinction is between two categories. Some products are minimally manipulated and used for the same basic function, which places them in one regulatory group. Others are 351 products that require approval. Calling the first group “FDA approved” is wrong. Our post on how 361 and 351 products differ explains it.
What this means for your practice: Know the accurate answer for each service you offer. Exosomes have no approved products. PRP involves a device nuance. Stem cell products turn on class. Train to the accurate version.
Why The Wrong Answer Creates Serious Legal Risk
Getting this wrong is not a small mistake. There are three failure modes, and each carries real exposure. Know them so you can avoid them.
The first is saying “yes, FDA approved” when it is not. This is mislabeling under FDA rules and a deceptive claim under FTC rules. It is the clearest violation of the three.
The second is saying “FDA cleared” when there is no 510(k) clearance for that use. Clearance is a specific thing. Claiming it without basis is the same kind of problem as claiming approval.
The third is the quiet one. Staying silent and letting the patient assume approval. When a patient believes a product is approved and you do nothing to correct it, that can be a constructive misrepresentation. Silence is not always safe.
The consequences are real. You can read the FDA’s overview of warning and close-out letters, and the FTC’s health products guidance covers implied claims.
What this means for your practice: Do not claim approval you do not have, do not claim clearance you do not have, and do not let silence imply either. All three are failure modes with real consequences.
The Channel-By-Channel Answer Guide
The accurate answer is the same everywhere. The delivery changes by channel. Here is how to handle each one.
| Channel | Context | Compliant Answer Framework |
|---|---|---|
| Website service page | Patient reading the page | Inline statement: “There are currently no FDA-approved exosome products. We explain what this means for our approach in consultations.” |
| Social media comment | Public comment asking about approval | Educational deflection: state the accurate status, then invite to consultation |
| DM or private message | Patient asking directly | Accurate status, then redirect to consultation for individual discussion, no health specifics in DM |
| Consultation, in-person | Patient asks verbally | Honest, detailed explanation of classification and what it means for their decision |
| Review response | Patient mentions FDA in a review | Accurate status in response, no patient health specifics, per HIPAA |
| Email follow-up | Patient asks after a consult | Accurate status, a link to an educational page, and a consultation invitation |
Two things stay constant across the table. The status is always accurate, and public channels never include patient health specifics. The DM and review rows matter most for privacy. Our HIPAA guidance for public responses covers that side, and the HIPAA overview from HHS covers the underlying privacy rules.
What this means for your practice: Use the same accurate status in every channel, and keep health specifics out of public ones. The framework changes, the honesty does not.
The FDA Terminology Glossary
Most of the confusion comes from four FDA terms that sound alike and mean different things. Here is what each one actually means, and how it gets misused.
| Term | What It Means | Common Misuse in Regen Marketing |
|---|---|---|
| FDA Approved | FDA reviewed safety and efficacy data and approved the specific product for a specific use | Applied to procedures or products that have not gone through the approval process |
| FDA Cleared (510(k)) | FDA found the device is substantially equivalent to a legally marketed predicate device | Applied to biologics, which go through a different pathway |
| FDA Registered | The facility is registered with FDA, which does not indicate product approval or clearance | Used to imply product approval |
| FDA Compliant | Not an official FDA designation, means the product or practice follows applicable FDA rules | Used vaguely to imply more than it means |
| Minimally Manipulated, Same Surgical Use (361) | HCT/Ps that meet these criteria are exempt from premarket approval, which does not mean FDA approved | Used as a synonym for “FDA approved” |
Read that table closely, because the differences are where clinics slip. “Registered” is about the facility, not the product. “Compliant” is not an official FDA term at all. And meeting the 361 criteria is not the same as approval.
What this means for your practice: Approved, cleared, registered, and compliant are four different things. Use the precise term for your situation, and never let one stand in for another.
How To Train Front Desk And Marketing Staff
The accurate answer only helps if everyone gives it. That means training, and it can be simple. A one-page script does the job.
Put the accurate status for each service in writing. Add the one-line version for quick questions and the longer version for consults. Give your team the channel rules: accurate status everywhere, no health specifics in public.
Then practice it. Walk through the common questions until the answer is automatic. The goal is that any person speaking for your clinic gives the same honest response, whether at the front desk or in a DM.
What this means for your practice: Write a one-page answer script and train your whole team on it. Consistency is the point. The right answer given by only some of your staff is still a risk.
Why Honest Transparency Is A Trust Signal
Some clinics fear the honest answer will cost them patients. With cash-pay regen patients, the opposite is usually true. Honesty is what they are looking for.
These patients research carefully and spend their own money. They have read about FDA status before they call. When you answer honestly, you confirm you are trustworthy. When you dodge, you confirm their suspicion that something is off. Our post on how cash-pay patients research covers this mindset.
Transparency on FDA status is a trust signal, not a sales problem. The clinic that answers clearly earns the confidence of a skeptical buyer. The one that gets vague loses it. Honest FDA status sits right alongside the other trust signals on a regen website.
What this means for your practice: The honest answer builds trust with the exact buyer you want. Vagueness reads as a red flag. Treat transparency on FDA status as a marketing advantage.
How This Looks In Practice
Picture a regen clinic that used vague FDA language for years.
The Challenge: The clinic’s website and staff gave fuzzy answers about FDA status. They worried the honest answer would scare patients off. So they deflected, and patients left unsure what they were actually getting.
The Approach: They rewrote their service pages with the accurate status stated plainly. They built a one-page answer script and trained the whole team. They set the channel rules: accurate status everywhere, no health specifics in public.
The Compliance Check: Their pages no longer implied approval they did not have. Their DM and review responses stayed free of health specifics. Their staff gave the same honest answer every time. The exosome status was stated plainly and accurately.
The Result: The patients who booked came in already trusting the clinic, because the clinic had been straight with them. The honest answer they feared would cost consults actually raised the quality of the ones they got. Transparency converted the skeptical buyer.
Frequently Asked Questions
Is exosome therapy FDA approved? No. There are currently no FDA-approved exosome products for human use. State this plainly in your marketing, and point to the FDA as the source. Our exosome posts cover the compliant language. The exosome marketing rules for 2026 go deeper.
Can I say my procedure uses FDA-approved equipment? Be careful here. A device may be FDA-cleared for a specific use, which is not the same as “FDA approved,” and the procedure itself is a separate thing. Saying “FDA-approved equipment” can imply the treatment is approved when it is not. State the device’s actual status precisely.
What is the difference between FDA approved and FDA registered? Approved means the FDA reviewed and approved a specific product for a specific use. Registered means the facility is registered with the FDA, which says nothing about product approval. Using “registered” to imply approval is a common and risky misuse.
Is “FDA compliant” a real designation? No. “FDA compliant” is not an official FDA label. It loosely means following applicable FDA rules, but it is often used vaguely to imply more than it means. Avoid using it as if it carries official weight.
How do I explain this without losing the patient? Be honest and confident, and frame it around your approach. State the accurate status, then explain what it means for their decision and how a consult addresses their situation. Cash-pay patients respond to honesty, so the accurate answer usually helps you, not hurts you.
What do I say if a patient asks about FDA status in a public review? Give the accurate status in your response, and include no patient health specifics. Confirming someone is a patient or discussing their care in public is a HIPAA problem. Keep the reply accurate and general.
Can my front desk answer this, or only the provider? Your front desk can give the accurate short version with the right script. The detailed explanation belongs in a consult. Train everyone on the one-line answer and the channel rules so the response is consistent no matter who gives it.
Key Takeaways
- “Is this FDA approved?” is the most important and most mishandled question in regen marketing.
- There are currently no FDA-approved exosome products. PRP and stem cell answers have specific nuances.
- Three failure modes carry real risk: claiming approval, claiming clearance, and letting silence imply either.
- The accurate status is the same in every channel, but the delivery changes by channel.
- Keep patient health specifics out of public responses like comments and reviews.
- Approved, cleared, registered, and compliant are four different things. Use the precise term.
Answer The Question And Earn The Trust
PS: The “Is this FDA approved?” question is a compliance checkpoint and a trust opportunity at the same time. The clinic that answers it honestly and clearly earns more qualified consultations than the one that deflects or gets it wrong. We build the messaging frameworks that handle this correctly across every channel. Reach out at [email protected], or subscribe on YouTube at https://www.youtube.com/@oatellez.
Compliance Disclaimer This article is educational and does not constitute legal, medical, or regulatory advice. It reflects publicly available information that can change as regulations, enforcement priorities, and platform policies evolve. It does not promise any marketing outcome or specific compliance result. Before acting on anything here, have your own marketing reviewed by qualified legal counsel familiar with FDA, FTC, HIPAA, and the advertising rules in your state.
About Regen Portal: Regen Portal is a marketing company serving the regenerative medicine industry. We provide SEO, content creation, social media management, paid advertising, website development, and branding services for clinics, manufacturers, distributors, and independent providers. Some strategies discussed in our educational content align with services we offer. For more on how we work, contact us.
About Oscar Tellez: Oscar Tellez is the founder of Regen Portal, a marketing company built for the regenerative medicine industry. With over 15 years of experience spanning clinical operations, product distribution, and digital marketing, Oscar has helped hundreds of practices, manufacturers, and distributors grow through compliant, high-performance marketing strategies. He holds a B.S. in Exercise Physiology and Health Promotion from Florida Atlantic University.
